As the spring conference season comes to an end, we’re reflecting on what we learned and identifying practical ways we can support clinical researchers, healthcare providers, and patients. Because...
Read More
For decades, researchers and government agencies have had their eyes on diversity in clinical trials. On April 13, The U.S. Food and Drug Administration issued a draft guidance recommending that...
Read More
At 20/20 Onsite, we pride ourselves on providing excellent customer service and a great patient experience. As Clinical Trial Manager, Pamela Tomic plays a pivotal role in our team’s ability to build...
Read More
COVID-19 has forever altered the future of clinical research, and WCG Clinical suggests that clinical research sites have felt the impact most of all. In an effort to support high-quality clinical...
Read More
Dr. Peter Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a leading clinical researcher of retinal disorders. With contributions to 7 textbooks, 30 book...
Read More
The time it takes to complete clinical trials has been steadily rising for over a decade, as treatments and their regulations become more complex. By reducing the time it takes to complete clinical...
Read More
Pharma Intelligence recently published a white paper titled “Rare Disease Trial Strategies” that piqued our team’s interest in how we may be able to help sponsors, CROs, and sites address some of the...
Read More
A recent study by WCG highlighted some of the top post-pandemic clinical trial enrollment challenges sites and sponsors are facing in 2022. Not surprisingly, COVID-19 has completely altered the way...
Read More